Korte W, Clarke, Susan, Lefkowitz, Jerry B. (January 2000). "Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism". American Journal of Clinical Pathology. 113 (1): 123–7. doi:10.1309/G98J-ANA9-RMNC-XLYU. PMID10631865. S2CID37642249.
Amiral J, Vissac AM, Seghatchian J (December 2017). "Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay". Transfus Apher Sci. 56 (6): 906–913. doi:10.1016/j.transci.2017.11.021. PMID29162399.
Hammami M. "MD". Medscape. WebMD LLC. Retrieved 25 July 2024.
nih.gov
pubmed.ncbi.nlm.nih.gov
Korte W, Clarke, Susan, Lefkowitz, Jerry B. (January 2000). "Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism". American Journal of Clinical Pathology. 113 (1): 123–7. doi:10.1309/G98J-ANA9-RMNC-XLYU. PMID10631865. S2CID37642249.
Amiral J, Vissac AM, Seghatchian J (December 2017). "Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay". Transfus Apher Sci. 56 (6): 906–913. doi:10.1016/j.transci.2017.11.021. PMID29162399.
Langdell RD, Wagner RH, Brinkhous KM (1953). "Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure". J. Lab. Clin. Med. 41 (4): 637–47. PMID13045017.
Korte W, Clarke, Susan, Lefkowitz, Jerry B. (January 2000). "Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism". American Journal of Clinical Pathology. 113 (1): 123–7. doi:10.1309/G98J-ANA9-RMNC-XLYU. PMID10631865. S2CID37642249.